Cargando…

Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction

Detalles Bibliográficos
Autores principales: Morales-Ponce, Francisco J., González-Pérez, Pablo, Blasco-Turrión, Sara, Sánchez-Brotons, Juan Antonio, Collado-Moreno, Carmen, Martínez-Romero, Pedro, Martínez-Morentín, Eduardo, Caro-Mateo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105071/
https://www.ncbi.nlm.nih.gov/pubmed/33438179
http://dx.doi.org/10.5603/CJ.a2021.0002
_version_ 1783689537311997952
author Morales-Ponce, Francisco J.
González-Pérez, Pablo
Blasco-Turrión, Sara
Sánchez-Brotons, Juan Antonio
Collado-Moreno, Carmen
Martínez-Romero, Pedro
Martínez-Morentín, Eduardo
Caro-Mateo, Pilar
author_facet Morales-Ponce, Francisco J.
González-Pérez, Pablo
Blasco-Turrión, Sara
Sánchez-Brotons, Juan Antonio
Collado-Moreno, Carmen
Martínez-Romero, Pedro
Martínez-Morentín, Eduardo
Caro-Mateo, Pilar
author_sort Morales-Ponce, Francisco J.
collection PubMed
description
format Online
Article
Text
id pubmed-8105071
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-81050712021-05-10 Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction Morales-Ponce, Francisco J. González-Pérez, Pablo Blasco-Turrión, Sara Sánchez-Brotons, Juan Antonio Collado-Moreno, Carmen Martínez-Romero, Pedro Martínez-Morentín, Eduardo Caro-Mateo, Pilar Cardiol J Clinical Cardiology Via Medica 2021-02-25 /pmc/articles/PMC8105071/ /pubmed/33438179 http://dx.doi.org/10.5603/CJ.a2021.0002 Text en Copyright © 2021 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
spellingShingle Clinical Cardiology
Morales-Ponce, Francisco J.
González-Pérez, Pablo
Blasco-Turrión, Sara
Sánchez-Brotons, Juan Antonio
Collado-Moreno, Carmen
Martínez-Romero, Pedro
Martínez-Morentín, Eduardo
Caro-Mateo, Pilar
Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
title Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
title_full Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
title_fullStr Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
title_full_unstemmed Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
title_short Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
title_sort effects of intracoronary antithrombotics on ventricular function: a comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
topic Clinical Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105071/
https://www.ncbi.nlm.nih.gov/pubmed/33438179
http://dx.doi.org/10.5603/CJ.a2021.0002
work_keys_str_mv AT moralesponcefranciscoj effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT gonzalezperezpablo effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT blascoturrionsara effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT sanchezbrotonsjuanantonio effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT colladomorenocarmen effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT martinezromeropedro effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT martinezmorentineduardo effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction
AT caromateopilar effectsofintracoronaryantithromboticsonventricularfunctionacomparisonoftenecteplaseversusabciximabduringprimarypercutaneousinterventioninmyocardialinfarction